Michaela Hoag
-
Committed to Memory: VU319 may hold the key to improving memory loss in Alzheimer’s patients
VU319, an investigational drug product developed by Vanderbilt researchers, targets one of medicine’s most bedeviling challenges: improving memory loss in people with Alzheimer’s disease. Read MoreJul 23, 2020